You may also like
Peripheral Extracorporeal Membrane Oxygenation System as Salvage Treatment of Patients with Refractory Cardiogenic Shock: Preliminary Outcome Evaluation
The novel Permanent Life Support (PLS; Maquet, Jostra Medizintechnik AG, Hirrlingen, Germany) as peripheral veno-arterial extracorporeal membrane oxygenation (ECMO) support system has been investigated as treatment for patients with refractory cardiogenic shock (CS).
1 min read
Bayer Pulls Trasylol From Market
Bayer HealthCare Pharmaceuticals Inc. has notified the FDA that the company will begin removing the remaining Trasylol stock from the U.S. market, most of which is in warehouses and hospital or physician’s stock. The FDA will work with Bayer to ensure a smooth and complete process.
3 min read